» Articles » PMID: 22807452

Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Jul 19
PMID 22807452
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Transmission of prions to a new host is frequently accompanied by strain adaptation, a phenomenon that involves reduction of the incubation period, a change in neuropathological features and, sometimes, tissue tropism. Here we show that a strain of synthetic origin (SSLOW), although serially transmitted within the same species, displayed the key attributes of the strain adaptation process. At least four serial passages were required to stabilize the strain-specific SSLOW phenotype. The biological titration of SSLOW revealed a correlation between clinical signs and accumulation of PrP(Sc) in brains of animals inoculated with high doses (10(-1)-10(-5) diluted brain material), but dissociation between the two processes at low dose inocula (10(-6)-10(-8) diluted brain material). At low doses, several asymptomatic animals harbored large amounts of PrP(Sc) comparable with those seen in the brains of terminally ill animals, whereas one clinically ill animal had very little, if any, PrP(Sc). In summary, the current study illustrates that the phenomenon of prion strain adaptation is more common than generally thought and could be observed upon serial transmission without changing the host species. When PrP(Sc) is seeded by recombinant PrP structures different from that of authentic PrP(Sc), PrP(Sc) properties continued to evolve for as long as four serial passages.

Citing Articles

Multiple steps of prion strain adaptation to a new host.

Bocharova O, Makarava N, Pandit N, Molesworth K, Baskakov I Front Neurosci. 2024; 18:1329010.

PMID: 38362022 PMC: 10867973. DOI: 10.3389/fnins.2024.1329010.


Region-Specific Homeostatic Identity of Astrocytes Is Essential for Defining Their Response to Pathological Insults.

Makarava N, Mychko O, Molesworth K, Chang J, Henry R, Tsymbalyuk N Cells. 2023; 12(17).

PMID: 37681904 PMC: 10486627. DOI: 10.3390/cells12172172.


Reactive astrocytes associated with prion disease impair the blood brain barrier.

Kushwaha R, Li Y, Makarava N, Pandit N, Molesworth K, Birukov K Neurobiol Dis. 2023; 185:106264.

PMID: 37597815 PMC: 10494928. DOI: 10.1016/j.nbd.2023.106264.


Reactive astrocytes associated with prion disease impair the blood brain barrier.

Kushwaha R, Li Y, Makarava N, Pandit N, Molesworth K, Birukov K bioRxiv. 2023; .

PMID: 36993690 PMC: 10055297. DOI: 10.1101/2023.03.21.533684.


Deficiency in ST6GAL1, one of the two α2,6-sialyltransferases, has only a minor effect on the pathogenesis of prion disease.

Makarava N, Katorcha E, Chang J, Lau J, Baskakov I Front Mol Biosci. 2022; 9:1058602.

PMID: 36452458 PMC: 9702343. DOI: 10.3389/fmolb.2022.1058602.


References
1.
Peretz D, Williamson R, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G . Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 2001; 412(6848):739-43. DOI: 10.1038/35089090. View

2.
Bailey J, Berardinelli J, Rocke T, Bessen R . Prominent pancreatic endocrinopathy and altered control of food intake disrupt energy homeostasis in prion diseases. J Endocrinol. 2008; 197(2):251-63. DOI: 10.1677/JOE-07-0516. View

3.
Makarava N, Savtchenko R, Alexeeva I, Rohwer R, Baskakov I . Fast and ultrasensitive method for quantitating prion infectivity titre. Nat Commun. 2012; 3:741. PMC: 3518416. DOI: 10.1038/ncomms1730. View

4.
Deleault N, Piro J, Walsh D, Wang F, Ma J, Geoghegan J . Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A. 2012; 109(22):8546-51. PMC: 3365173. DOI: 10.1073/pnas.1204498109. View

5.
CHANDLER R, Turfrey B . Inoculation of voles, Chinese hamsters, gerbils and guinea-pigs with scrapie brain material. Res Vet Sci. 1972; 13(3):219-24. View